TDMS Study 88133-06 Pathology Tables
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TRIMETHYLOLPROPANE TRIACRYLATE DATE: 10/30/02
EXPERIMENT: 88133 TEST: 06 TIME: 10:08:39
TEST TYPE: SUBCHRON 26-WEEK PAGE: 1
CONT: NO1-ES-65406 ROUTE: SKIN APPLICATION NTP C#: 88133B
PATHOLOGIST: TOFT, JOHN CAS: 15625-89-5
------------------------------------------------------------------------------------------------------------------------------------
Final#3
REASONS FOR REMOVAL: ALL
REMOVAL DATE RANGE: ALL
TREATMENT GROUPS: INCLUDE 001 0 MG/KG
INCLUDE 002 0 MG/KG
INCLUDE 003 0.75 MG/KG
INCLUDE 004 0.75 MG/KG
INCLUDE 005 1.5 MG/KG
INCLUDE 006 1.5 MG/KG
INCLUDE 007 3 MG/KG
INCLUDE 008 3 MG/KG
INCLUDE 009 6 MG/KG
INCLUDE 010 6 MG/KG
INCLUDE 011 12 MG/KG
INCLUDE 012 12 MG/KG
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TRIMETHYLOLPROPANE TRIACRYLATE DATE: 10/30/02
EXPERIMENT: 88133 TEST: 06 TIME: 10:08:39
TEST TYPE: SUBCHRON 26-WEEK
CONT: NO1-ES-65406 ROUTE: SKIN APPLICATION NTP C#: 88133B
PATHOLOGIST: TOFT, JOHN CAS: 15625-89-5
Mice(TG.AC HETEROZYGOUS TRANSGENIC)
-----------------------------
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE
BASED ON NUMBER OF TISSUES EXAMINED. IN OTHER TISSUES/ORGANS RATES
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.
---------------
Lung
Salivary Glands
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TRIMETHYLOLPROPANE TRIACRYLATE DATE: 10/30/02
EXPERIMENT: 88133 TEST: 06 TIME: 10:08:39
TEST TYPE: SUBCHRON 26-WEEK
CONT: NO1-ES-65406 ROUTE: SKIN APPLICATION NTP C#: 88133B
PATHOLOGIST: TOFT, JOHN CAS: 15625-89-5
SUMMARY OF STATISTICALLY SIGNIFICANT (P